Systemic administration of the antisense oligonucleotide NS-065/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy.
about
NS-065/NCNP-01: An Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular DystrophyShorter Phosphorodiamidate Morpholino Splice-Switching Oligonucleotides May Increase Exon-Skipping Efficacy in DMDDistribution of Antisense Oligonucleotides in Rat Eyeballs Using MALDI Imaging Mass Spectrometry
P2860
Systemic administration of the antisense oligonucleotide NS-065/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Systemic administration of the ...... h Duchenne muscular dystrophy.
@en
Systemic administration of the ...... h Duchenne muscular dystrophy.
@nl
type
label
Systemic administration of the ...... h Duchenne muscular dystrophy.
@en
Systemic administration of the ...... h Duchenne muscular dystrophy.
@nl
prefLabel
Systemic administration of the ...... h Duchenne muscular dystrophy.
@en
Systemic administration of the ...... h Duchenne muscular dystrophy.
@nl
P2093
P50
P1476
Systemic administration of the ...... th Duchenne muscular dystrophy
@en
P2093
Eri Takeshita
Harumasa Nakamura
Hisateru Tachimori
Satoru Masuda
Yoshitsugu Aoki
P356
10.1126/SCITRANSLMED.AAN0713
P407
P577
2018-04-01T00:00:00Z